Inactive Instrument
GlobeImmune Inc Stock Nasdaq
Stocks
US37957B1008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.67M 1.44M 1.35M 1.24M 2.34M 159M 2.36M 15.82M 6.21M 79.36M 6.26M 6.13M 263M | P/E 2014 |
-0.94x | P/E 2015 | -8.04x |
|---|---|---|---|---|---|
| Enterprise Value | -8.23M -7.13M -6.65M -6.11M -11.54M -783M -11.67M -78.11M -30.66M -392M -30.92M -30.24M -1.3B | EV / Sales 2014 |
4.5x | EV / Sales 2015 | 1.91x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| 1 day | -24.08% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.08% | -1.30% | - | - | 5 | |
| +4.35% | +19.90% | +60.59% | +95.21% | 62.53B | |
| +2.83% | -3.48% | +24.97% | +69.33% | 52.43B | |
| -0.27% | -2.26% | -18.20% | -7.77% | 23.1B | |
| +1.89% | -2.54% | -9.95% | +359.53% | 21.4B | |
| +0.40% | +5.29% | +30.11% | -9.63% | 21.17B | |
| +0.75% | +1.34% | +32.22% | -25.54% | 17.76B | |
| +9.88% | +19.73% | +229.67% | +385.49% | 15.47B | |
| +2.08% | -3.28% | +21.67% | +564.59% | 14.68B | |
| +0.32% | +1.46% | +49.87% | +177.23% | 14.08B | |
| Average | -0.19% | +3.65% | +46.77% | +178.72% | 26.96B | |
| Weighted average by Cap. | +2.73% | +4.59% | +42.23% | +136.81% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 5.97M 5.17M 4.82M 4.43M 8.36M 567M 8.46M 56.61M 22.22M 284M 22.41M 21.91M 940M | 6.46M 5.59M 5.21M 4.8M 9.05M 614M 9.15M 61.27M 24.05M 307M 24.25M 23.72M 1.02B |
| Net income | -16.26M -14.08M -13.13M -12.07M -22.8M -1.55B -23.05M -154M -60.55M -774M -61.07M -59.73M -2.56B | -2.77M -2.4M -2.23M -2.05M -3.88M -263M -3.92M -26.25M -10.3M -132M -10.39M -10.16M -436M |
| Net Debt | -16.81M -14.56M -13.57M -12.48M -23.57M -1.6B -23.83M -160M -62.6M -800M -63.14M -61.75M -2.65B | -9.9M -8.58M -7.99M -7.35M -13.88M -941M -14.03M -93.93M -36.87M -471M -37.19M -36.37M -1.56B |
Employees
-
